Reclast Infusion Center Analysis August 4, 2008
16
1 Reclast Infusion Center Analysis August 4, 2008
-
Upload
avram-french -
Category
Documents
-
view
21 -
download
0
description
Reclast Infusion Center Analysis August 4, 2008. Key Findings. 93% of Bone-Uro and Geigy targets have infusion access within 10 miles. However, the number infusion centers might not be sufficient to meet patient needs in a region or a district. 45.1K targets have infusion access within 10 miles - PowerPoint PPT Presentation
Transcript of Reclast Infusion Center Analysis August 4, 2008
1
ReclastInfusion Center Analysis
August 4, 2008
ReclastInfusion Center Analysis
August 4, 2008
2
Key Findings
93% of Bone-Uro and Geigy targets have infusion access within 10 miles. However, the number infusion centers might not be sufficient to meet patient needs in a region or a district.• 45.1K targets have infusion access within 10 miles• 3.3K targets do not have infusion access within 10 miles
There is a positive relationship between Reclast sales and the number of infusion centers • As the number of infusion centers increases, Reclast sales increase
3
Infusion Center Access in Geigy Regions
4
Geigy Region: Atlanta 5,821 targets have infusion access within 10 miles (black dots)
428 targets do not have infusion access within 10 miles (red triangles)
5
Geigy Region: Boston 4.606 targets have infusion access within 10 miles (black dots)
218 targets do not have infusion access within 10 miles (red triangles)
6
Geigy Region: Chicago 7,426 targets have infusion access within 10 miles (black dots)
550 targets do not have infusion access within 10 miles (red triangles)
7
Geigy Region: Cincinnati 6,339 targets have infusion access within 10 miles (black dots)
350 targets do not have infusion access within 10 miles (red triangles)
8
Geigy Region: Dallas 5,661 targets have infusion access within 10 miles (black dots)
573 targets do not have infusion access within 10 miles (red triangles)
9
Geigy Region: Morristown 4,828 targets have infusion access within 10 miles (black dots)
278 targets do not have infusion access within 10 miles (red triangles)
10
Geigy Region: Raleigh 5,141 targets have infusion access within 10 miles (black dots)
512 targets do not have infusion access within 10 miles (red triangles)
11
Geigy Region: San Ramon 5,109 targets have infusion access within 10 miles (black dots)
307 targets do not have infusion access within 10 miles (red triangles)
13
Relationship between Reclast Sales and Infusion Access Using Bone-Uro District Data
15
Bone/Uro Districts: Correlation between Reclast sales and Reclast Ready sites is 0.60
There is a positive association between Reclast sales and Reclast Ready sites
0
100
200
300
400
500
600
700
KA
NS
AS
CIT
Y
NA
SH
VIL
LE
AT
LA
NT
A
DE
TR
OIT
TA
MP
A
PIT
TS
BU
RG
H
CH
ICA
GO
HO
US
TO
N
BO
ST
ON
SA
N F
RA
NC
ISC
O
WA
SH
ING
TO
N D
C
PH
ILA
DE
LP
HIA
DA
LL
AS
LO
S A
NG
EL
ES
NE
W Y
OR
K
Re
cla
st R
ea
dy
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
%R
ecla
st S
ale
s/%
BP
TR
xs
Reclast Ready %Reclast Sales/%BP TRxs
Data ending June 2008
17
Bone/Uro Districts: Correlation between Reclast sales and estimated 65+ women patients per Reclast Ready facility is -0.76 There is a positive association between sales and Reclast Ready sites
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
5,000
KA
NS
AS
CIT
Y
NA
SH
VIL
LE
AT
LA
NT
A
DE
TR
OIT
TA
MP
A
PIT
TS
BU
RG
H
CH
ICA
GO
HO
US
TO
N
BO
ST
ON
SA
N F
RA
NC
ISC
O
WA
SH
ING
TO
N D
C
PH
ILA
DE
LP
HIA
DA
LL
AS
LO
S A
NG
EL
ES
NE
W Y
OR
K
Pa
tie
nts
/RR
Fa
cility
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
%R
ecla
st S
ale
s/%
BP
TR
xs
Est. 65+ Women Patient per RR Facility %Reclast Sales/%BP TRxs
Estimated 65+ Women Patients = 55% of 65+ Women
Data ending June 2008
18
Bone-Uro Districts: Correlation between estimated 65+ women patients and oral BP TRxs is 0.90 but correlation between 65+ Women patients and Reclast sales is only 0.42
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000K
AN
SA
S C
ITY
NA
SH
VIL
LE
AT
LA
NT
A
DE
TR
OIT
TA
MP
A
PIT
TS
BU
RG
H
CH
ICA
GO
HO
US
TO
N
BO
ST
ON
SA
N F
RA
NC
ISC
O
WA
SH
ING
TO
N D
C
PH
ILA
DE
LP
HIA
DA
LL
AS
LO
S A
NG
EL
ES
NE
W Y
OR
K
Ora
l B
P T
Rxs &
Est. 6
5+
W P
atie
nts
$0
$2
$4
$6
$8
$10
$12
Millio
ns
Re
cla
st S
ale
s
Est. 65+ Women Patients BPTRX Reclast Sales
Estimated 65+ Women Patients = 55% of 65+ Women
Data ending June 2008
19
Back-UpInfusion Center Access in Bone-Uro Districts
